There have been many ethical concerns about the cervical cancer vaccine Gardasil, which all began with politics and Merck’s lobbying for the vaccination. According to Charo, controversy began with Merck’s “lobbying” of states to oblige to vaccination against HPV to lead the company to “drop tactics” (2009). He also states within the United States, state legislatures are struggling to respond to the availability of Merck’s HPV vaccine Gardasil (Charo, 2009). Three
There have been many ethical concerns about the cervical cancer vaccine Gardasil, which all began with politics and Merck’s lobbying for the vaccination. According to Charo, controversy began with Merck’s “lobbying” of states to oblige to vaccination against HPV to lead the company to “drop tactics” (2009). He also states within the United States, state legislatures are struggling to respond to the availability of Merck’s HPV vaccine Gardasil (Charo, 2009). Three